Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/30548
Title: Genome-wide analyses of 200,453 individuals yield new insights into the causes and consequences of clonal hematopoiesis.
Austin Authors: Kar, Siddhartha P;Quiros, Pedro M;Gu, Muxin;Jiang, Tao;Mitchell, Jonathan;Langdon, Ryan;Iyer, Vivek;Barcena, Clea;Vijayabaskar, M S;Fabre, Margarete A;Carter, Paul;Petrovski, Slavé;Burgess, Stephen;Vassiliou, George S
Affiliation: MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK..
Department of Haematology, Wellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK..
Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK..
BHF Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, Strangeways Research Laboratory, University of Cambridge, Cambridge, UK..
Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK..
Medicine (University of Melbourne)
MRC Biostatistics Unit, University of Cambridge, Cambridge, UK..
Department of Haematology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK..
Division of Cardiovascular Medicine, Department of Medicine, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK..
Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK..
BHF Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, Strangeways Research Laboratory, University of Cambridge, Cambridge, UK..
Section of Translational Epidemiology, Division of Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK..
Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain..
Issue Date: 14-Jul-2022
Date: 2022
Publication information: Nature Genetics 2022; 54(8): 1155-1166
Abstract: Clonal hematopoiesis (CH), the clonal expansion of a blood stem cell and its progeny driven by somatic driver mutations, affects over a third of people, yet remains poorly understood. Here we analyze genetic data from 200,453 UK Biobank participants to map the landscape of inherited predisposition to CH, increasing the number of germline associations with CH in European-ancestry populations from 4 to 14. Genes at new loci implicate DNA damage repair (PARP1, ATM, CHEK2), hematopoietic stem cell migration/homing (CD164) and myeloid oncogenesis (SETBP1). Several associations were CH-subtype-specific including variants at TCL1A and CD164 that had opposite associations with DNMT3A- versus TET2-mutant CH, the two most common CH subtypes, proposing key roles for these two loci in CH development. Mendelian randomization analyses showed that smoking and longer leukocyte telomere length are causal risk factors for CH and that genetic predisposition to CH increases risks of myeloproliferative neoplasia, nonhematological malignancies, atrial fibrillation and blood epigenetic ageing.
URI: https://ahro.austin.org.au/austinjspui/handle/1/30548
DOI: 10.1038/s41588-022-01121-z
ORCID: http://orcid.org/0000-0002-2314-1426
http://orcid.org/0000-0002-7793-6291
http://orcid.org/0000-0001-5365-8760
http://orcid.org/0000-0003-4337-8022
http://orcid.org/0000-0002-1527-961X
Journal: Nature genetics
PubMed URL: 35835912
PubMed URL: https://pubmed.ncbi.nlm.nih.gov/35835912/
Type: Journal Article
Appears in Collections:Journal articles

Show full item record

Page view(s)

24
checked on Nov 23, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.